×
About 835 results

ALLMedicine™ Injecting Drug Use Center

Research & Reviews  307 results

Recurrent Injecting Drug Use as a Mediator between Psychiatric Disorder and Non-Fatal O...
https://doi.org/10.1080/10826084.2022.2076877
Substance Use & misUse; Barnes DM, Xu S et. al.

May 26th, 2022 - Unintentional drug overdose has increased markedly in the United States. Studies document an association between psychiatric disorder and unintentional overdose; we extend this research through a preliminary test of a causal model of recurrent inj...

Registry-based HCV Care Cascade Navigation at Atlanta's Grady Memorial Hospital
https://clinicaltrials.gov/ct2/show/NCT03441542

May 25th, 2022 - EZ-C's purpose is to determine the effectiveness of patient navigation services during treatment of hepatitis C compared to usual care among opioid substitution therapy (OST) and active injecting drug use (IDU) individuals. To recruit OST and acti...

Injection Drug Use
http://emedicine.medscape.com/article/286976-overview

Apr 19th, 2022 - Background With recent UN reports estimating that as many as 14.2 million individuals inject substances worldwide, injectable drug use continues to be a growing global concern given the increased risk for various health-related consequences faced ...

Injection Drug Use
https://emedicine.medscape.com/article/286976-overview

Apr 19th, 2022 - Background With recent UN reports estimating that as many as 14.2 million individuals inject substances worldwide, injectable drug use continues to be a growing global concern given the increased risk for various health-related consequences faced ...

Willingness of people who inject drugs to participate in a randomised controlled trial ...
https://doi.org/10.1016/j.drugalcdep.2022.109438
Drug and Alcohol Dependence; Marshall AD, Conway A et. al.

Apr 18th, 2022 - Evidence regarding the acceptability of contingency management is limited. We investigated the willingness of people who inject drugs to participate in a randomised controlled trial (RCT) involving financial incentives to initiate HCV treatment. E...

see more →

Drugs  1 results see all →

Clinicaltrials.gov  11 results

Registry-based HCV Care Cascade Navigation at Atlanta's Grady Memorial Hospital
https://clinicaltrials.gov/ct2/show/NCT03441542

May 25th, 2022 - EZ-C's purpose is to determine the effectiveness of patient navigation services during treatment of hepatitis C compared to usual care among opioid substitution therapy (OST) and active injecting drug use (IDU) individuals. To recruit OST and acti...

A Trial to Assess the Effect of an Intervention Integrating Contingency Management (Financial Incentives) to Enhance Hepatitis C Treatment Uptake Following Dried Blood Spot Hepatitis C RNA Testing ...
https://clinicaltrials.gov/ct2/show/NCT04428346

Apr 14th, 2022 - A pilot two-arm, individual-level, randomised controlled trial to assess the effect of an intervention integrating contingency management (financial incentives) to enhance hepatitis C treatment uptake following dried blood spot hepatitis C RNA tes...

Direct-acting Antiviral Therapy and Reinfection Among People With Chronic Hepatitis C Virus Infection and Recent Injecting Drug Use in the Prison Setting
https://clinicaltrials.gov/ct2/show/NCT03740906

Apr 14th, 2022 - In Australia, hepatitis C virus (HCV)-related morbidity and mortality have doubled in the past decade, with health care costs of $220 million per annum associated with approximately 200,000 chronically infected cases. The majority of new (90%) and...

ETHOS ENGAGE: Enhancing Treatment of Hepatitis C in Opioid Substitution Settings
https://clinicaltrials.gov/ct2/show/NCT03685045

Mar 31st, 2022 - The ETHOS II Project is a collaborative research project led by the Kirby Institute, UNSW Sydney, in partnership with: The Centre for Social Research in Health, UNSW Sydney NSW Health NSW Users and AIDS Association Hepatitis NSW Australasian Socie...

HealthCall:Brief Intervention to Reduce Non-injecting Drug Use in HIV Primary Care Clinics
https://clinicaltrials.gov/ct2/show/NCT01312181

Aug 17th, 2021 - Among HIV-infected individuals, non-injection drug use (NIDU) is associated with poor HIV medication adherence, greater HIV/AIDS risk behaviors, and increasing non-AIDS mortality. Thus reducing NIDU among HIV infected individuals is critical to th...

see more →

News  15 results

‘Reverse transitions’ from injecting to noninjecting drug use studied
https://www.mdedge.com/familymedicine/article/169460/addiction-medicine/reverse-transitions-injecting-noninjecting-drug-use
MDedge Psychiatry; Doug Brunk

Jul 3rd, 2018 - SAN DIEGO – The transition from noninjecting to injecting drug use can be a reversible process, results from a long-term study suggest. “There’s a common stereotype in popular culture and in academic research that once people start injecting drugs.

Fast Five Quiz: How Much Do You Know About Substance Abuse and Addiction?
https://reference.staging.medscape.com/viewarticle/838887_3

Feb 3rd, 2015 - Most individuals who use injection drugs inject their drugs intravenously, but subcutaneous injection (ie, "skin-popping") is also common, and intramuscular injection may occur intentionally or when the individual misses the vein or the subcutaneo...

Tenofovir Reduces HIV Infections in Injection Drug Users
https://www.medscape.com/viewarticle/805739

Jun 12th, 2013 - Preexposure prophylaxis (PrEP) with tenofovir disoproxil fumarate nearly halved (48.9%) HIV infection rates in injection drug users, according to a randomized, double-blind, placebo-controlled, phase 3 trial of 2413 participants in Thailand. Kachi...

Hepatitis Prevalence Among Drug Users Varies Greatly Worldwide
https://www.mdedge.com/psychiatry/article/36770/addiction-medicine/hepatitis-prevalence-among-drug-users-varies-greatly
Doug Brunk

Jul 27th, 2011 - Worldwide, an estimated 10 million injecting drug users have hepatitis C virus, while about 1. 2 million have hepatitis B virus, based on results from an innovative and comprehensive analysis.

"Harm reduction" needed to cut drug-user AIDS risk
https://www.reuters.com/article/us-aids-harm-reduction/harm-reduction-needed-to-cut-drug-user-aids-risk-idUSTRE63O2C120100425

Apr 25th, 2010 - LONDON (Reuters) - Barely a twentieth of the estimated $3.2 billion needed is put into preventing drug users spreading the AIDS virus, experts said on Monday, and the shortfall is fuelling HIV epidemics in parts of Europe and Asia. In a report on ...

see more →